KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 77,916 Value ($000) $3,214 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 49,817 Value ($000) $1,934 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 30,616 Value ($000) $847 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 49,989 Value ($000) $1,110 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 58,598 Value ($000) $1,159 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 49,507 Value ($000) $1,237 Avg Close $24.36 Range $17.38 - $27.92

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	77,916	$3,214	$40.11	$35.20 - $44.42
Q3 2025	49,817	$1,934	$32.49	$26.27 - $39.00
Q2 2025	30,616	$847	$25.46	$18.25 - $30.69
Q1 2025	49,989	$1,110	$20.58	$17.82 - $24.31
Q4 2024	58,598	$1,159	$22.82	$19.47 - $28.15
Q3 2024	49,507	$1,237	$24.36	$17.38 - $27.92